Bank of America Securities: Assigns "Buy" rating to ENN ENERGY (02688), dividend expected to release value.
The bank expects to confirm a dividend of at least HKD 3 per share for the first half of the year, thereby driving a reevaluation of its valuation, and is also optimistic about the company's mid-term shareholder returns.
Bank of America Securities has released a research report stating that it maintains a Buy rating for ENN ENERGY (02688) with a target price of HKD 60, believing that dividends are expected to unlock value first. The report noted that although gas costs remain high in the short term, it believes that ENN ENERGY's valuation has already reflected the associated challenges, and any geopolitical stability could bring upside risks. The firm pointed out that ENN ENERGY is currently trading at a discount compared to its peers, and its dividend yield is higher. Considering its lower leverage and stronger free cash flow, this discount is deemed unreasonable. The firm anticipates that the performance in the first half of the year will at least confirm a dividend of HKD 3 per share, thereby driving a revaluation, and they are optimistic about mid-term shareholder returns. In a basic scenario, the oversupply in the LNG market, along with reduced gas costs, will drive the next stage of increases.
Related Articles

HK Stock Market Move | LEADS BIOLABS-B (09887) rose over 3% as the phase II clinical research of WeiliXin for the first-line treatment of hepatocellular carcinoma successfully entered the expansion phase.

HK Stock Market Move | APEX ACE HLDG (06036) surged over 18% during trading, expecting the net profit attributable to shareholders for the first half of the year to grow to HKD 130 million to HKD 140 million compared to the same period last year.

HK Stock Market Move | The decline in storage concepts is significant, and the revenue guidance from US storage giants falls short of expectations, resulting in a transmission of sluggish sentiment to the Asia-Pacific market.
HK Stock Market Move | LEADS BIOLABS-B (09887) rose over 3% as the phase II clinical research of WeiliXin for the first-line treatment of hepatocellular carcinoma successfully entered the expansion phase.

HK Stock Market Move | APEX ACE HLDG (06036) surged over 18% during trading, expecting the net profit attributable to shareholders for the first half of the year to grow to HKD 130 million to HKD 140 million compared to the same period last year.

HK Stock Market Move | The decline in storage concepts is significant, and the revenue guidance from US storage giants falls short of expectations, resulting in a transmission of sluggish sentiment to the Asia-Pacific market.

RECOMMEND





